Conflicts of interest. IOM panel backs public disclosure of drug company payments
Kaiser, J.
Science 324(5927): 579
2009
ISSN/ISBN: 0036-8075 PMID: 19407172 DOI: 10.1126/science.324_579a
Accession: 052292136
PDF emailed within 0-6 h: $19.90
Related References
Charatan, F. 2007: Drug company payments to doctors still hard to access despite disclosure laws Bmj 334(7595): 655Moynihan, R. 2013: Australia moves closer to full disclosure of drug company payments to doctors BMJ 346: f3960
Campbell, E.G. 2010: Public disclosure of conflicts of interest: moving the policy debate forward Archives of Internal Medicine 170(8): 667
Kuschel, S.L.; Ricotti, C.M.; Dunnick, C.A.; Hugh, J.; Dellavalle, R.P. 2019: Analysis of conflicts of interest in pharmaceutical payments made to Food and Drug Administration physician advisers after dermatologic drug approval Journal of the American Academy of Dermatology 81(6): 1419-1420
Weed, D.L. 2009: Conflicts of interest. How could disclosure of interests work better in medicine, epidemiology and public health? Journal of Epidemiology and Community Health 63(8): 601-602
Williams, J.; Lipworth, W.; Mayes, C.; Olver, I.; Kerridge, I. 2017: Should disclosure of conflicts of interest in medicine be made public? Medical students' views Medical Education 51(12): 1232-1240
Spelsberg, A.; Martiny, A.; Schoenhoefer, P.S. 2009: Is disclosure of potential conflicts of interest in medicine and public health sufficient to increase transparency and decrease corruption? Journal of Epidemiology and Community Health 63(8): 603-605
Angela Spelsberg, A Martiny and P S Schoenhoefer 2009: Is disclosure of potential conflicts of interest in medicine and public health sufficient to increase transparency and decrease corruption? Journal of Epidemiology and Community Health 63(8): 603-605
Marcovitch, H. 2009: How could disclosure of interests work better in medicine, epidemiology and public health: How do potential conflicts of interest confuse medicine and public health? Journal of Epidemiology and Community Health 63(8): 608-609
Carlson, J. 2012: Doctors of interest. Recipients of suspect drug-company payments academic medical centers, have drawing attention of federal fraud enforcers Modern Healthcare 42(34): 6-7; 16, 1
Brahams, D. 1991: Drug-company data and the public interest Lancet 338(8765): 502-503
Baethge, C. 2013: The effect of a conflict of interest disclosure form using closed questions on the number of positive conflicts of interest declared - a controlled study Peerj 1: E128
Horton, W.W.; McFadden, F.H. 1999: Disclosure obligations of the newly public healthcare company: practical strategies for the company and its counsel Journal of Health Law 32(1): 1-38
Rickard, E.; Ozieranski, P.; Mulinari, S. 2019: Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK Health Policy 123(12): 1244-1250
Alhamoud, H.A.; Dudum, R.; Young, H.A.; Choi, B.G. 2016: Author Self-disclosure Compared with Pharmaceutical Company Reporting of Physician Payments American Journal of Medicine 129(1): 59-63
Wright, C.; Schnoll, S.; Bernstein, D. 2008: Risk evaluation and mitigation strategies for drugs with abuse liability: public interest, special interest, conflicts of interest, and the industry perspective Annals of the new York Academy of Sciences 1141: 284-303
Capps, B.; van der Eijk, Y.; Krahn, T.M. 2020: Conflicts of interest in e-cigarette research: A public good and public interest perspective Bioethics 34(1): 114-122
Ozieranski, P.; Martinon, L.; Jachiet, P.-A.; Mulinari, S. 2022: Tip of the Iceberg? Country- and Company-Level Analysis of Drug Company Payments for Research and Development in Europe International Journal of Health Policy and Management 2022
McCoy, M.S.; Pagán, O.; Donohoe, G.; Kanter, G.P.; Litman, R.S. 2018: Conflicts of Interest of Public Speakers at Meetings of the Anesthetic and Analgesic Drug Products Advisory Committee JAMA Internal Medicine 178(7): 996-997
Menkes, D.B. 2011: Tackling conflicts of interest. Conflicts of interest and drug information Bmj 343: D5617